Efficacy, safety and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double-blind, placebo controlled, randomised, multicentre study. - Pinter,M.M.; Pogarell,O.; Oertel,W.H. (J Neurol Neurosurg Psychiatry, 1999)